Radionetics Oncology
Clinical trials sponsored by Radionetics Oncology, explained in plain language.
-
New targeted therapy duo enters human trials for advanced breast cancer
Disease control Recruiting nowThis early-phase study tests two related drugs: one to help see tumors on scans (68Ga-R11228) and another to deliver radiation directly to cancer cells (177Lu-R11228). It is for people with advanced hormone-receptor positive breast cancer that has spread or come back. The main go…
Phase: PHASE1 • Sponsor: Radionetics Oncology • Aim: Disease control
Last updated Jun 16, 2026 12:51 UTC
-
Radioactive tracer could spot hidden breast cancer tumors
Diagnosis Recruiting nowThis early-phase trial is testing a new radioactive imaging agent called 68Ga-R10602 in 36 people with hormone receptor-positive breast cancer that has come back or spread. The agent is designed to light up tumors on PET/CT scans. The main goals are to check safety and see how we…
Phase: PHASE1 • Sponsor: Radionetics Oncology • Aim: Diagnosis
Last updated Jun 23, 2026 11:54 UTC